Alzheimer’s & Bacteria: Eye Infection Linked to Cognitive Decline | New Research
- A common bacterium, Chlamydia pneumoniae, is increasingly being linked to the development and progression of Alzheimer’s disease, according to recent research.
- Researchers at Cedars-Sinai Medical Center demonstrated that Chlamydia pneumoniae can induce inflammatory reactions, nerve cell death, and cognitive decline.
- “Seeing Chlamydia pneumoniae repeatedly in human tissues, cell cultures and animal models allowed us to identify a hitherto ignored link between bacterial infection, inflammation and neurodegeneration,” explained Professor...
A common bacterium, Chlamydia pneumoniae, is increasingly being linked to the development and progression of Alzheimer’s disease, according to recent research. Scientists have discovered the presence of this microbe not only in the brains of individuals with Alzheimer’s, but also in the retina of the eye, suggesting a potential new avenue for early detection and intervention.
Bacterial Presence Correlates with Disease Stage
Researchers at Cedars-Sinai Medical Center demonstrated that Chlamydia pneumoniae can induce inflammatory reactions, nerve cell death, and cognitive decline. Their study, published in Nature Communications, analyzed retinal and brain tissues from 104 individuals across varying stages of cognitive function – those with normal cognition, mild cognitive impairment, and confirmed Alzheimer’s disease. The study, completed on , revealed a significantly higher presence of the bacteria in those diagnosed with the neurodegenerative disease.
“Seeing Chlamydia pneumoniae repeatedly in human tissues, cell cultures and animal models allowed us to identify a hitherto ignored link between bacterial infection, inflammation and neurodegeneration,” explained Professor Maya Koronyo-Hamaoui, lead author of the study. The bacterial load appeared to correlate with the severity of brain alterations, and the risk was further elevated in individuals carrying the APOE4 gene, a known genetic risk factor for Alzheimer’s.
Inflammation and Neurodegeneration: A Complex Relationship
The research indicates that infection with Chlamydia pneumoniae triggers a cascade of events that contribute to Alzheimer’s pathology. In laboratory settings, the bacteria were shown to increase inflammation, promote the production of amyloid-beta protein (a hallmark of Alzheimer’s disease), and cause neuronal degradation in both cultured human neurons and in mouse models. These findings suggest a disease-amplifying role for the bacterium.
Further investigation revealed specific pathways involved in this process. The study identified activation of the NLRP3 inflammasome, a key component of the immune system, in the retina of individuals with mild cognitive impairment and in the brains of those with Alzheimer’s dementia. Activation of this inflammasome leads to increased levels of caspase-1, cleaved interleukin-1β, and cleaved N-terminal gasdermin-D – all indicators of inflammation and cell death.
The Eye as a Potential Biomarker
The discovery of Chlamydia pneumoniae in the retina raises the possibility of using eye imaging as a non-invasive method for detecting individuals at risk of developing Alzheimer’s disease. “The eye is a reflection of the brain, and this study shows that retinal infection and chronic inflammation can reflect brain pathology and predict disease progression,” stated Professor Koronyo-Hamaoui.
Researchers also noted a potential impairment in the clearance of the bacteria within the retinas of Alzheimer’s patients, suggesting a breakdown in the immune response. Fewer pathogen-colocalized microglia – immune cells responsible for clearing debris and pathogens – were observed in the retinas of those with Alzheimer’s, hinting at a diminished ability to combat the infection.
Broader Infection Links to Cognitive Decline
While Chlamydia pneumoniae is gaining attention, it’s not the only infection implicated in cognitive decline. A study published in Infectious Disease Advisor on , analyzing data from the Northern Manhattan Study, found associations between exposure to common infections and cognitive performance in older adults. Specifically, cytomegalovirus (CMV) and herpes simplex virus type 2 (HSV-2) were linked to poorer executive function, while Chlamydia pneumoniae was associated with reduced language performance.
The Northern Manhattan Study, which followed 593 participants (average age 71) for approximately 7.8 years, showed that 30% developed cognitive impairment and 17% were diagnosed with dementia during the follow-up period. These findings reinforce the idea that chronic infectious exposures may accelerate cognitive aging.
Potential Therapeutic Strategies
The emerging link between Chlamydia pneumoniae and Alzheimer’s disease opens up potential new therapeutic avenues. Researchers are exploring the possibility of using antibiotics, administered early in the disease process, to target the bacterial infection. Anti-inflammatory therapies aimed at modulating the NLRP3 inflammasome are being considered as a way to mitigate the inflammatory response and neurodegeneration.
Machine learning algorithms have shown promise in detecting Alzheimer’s disease and assessing its stage by analyzing retinal Chlamydia pneumoniae or NLRP3 levels in combination with amyloid-beta42 levels. This suggests a potential for more accurate and earlier diagnosis.
Further research is needed to fully understand the complex interplay between infection, inflammation, and neurodegeneration in Alzheimer’s disease. However, these recent findings provide compelling evidence for the importance of considering infectious agents as potential contributors to this devastating condition.